Ace the RRD 5 Challenge 2026 – Outshine in Disease Knowledge Today!

Normocytic anemia is characterized by a normal MCV despite low hemoglobin, usually due to underproduction of red cells or acute blood loss rather than nutritional deficiencies. A typical approach targets the underlying cause and may involve stimulating red cell production with erythropoietin, especially in underproduction states like chronic kidney disease or marrow suppression, and stopping ongoing blood loss to prevent further depletion. Iron supplementation is for iron-deficiency anemia (microcytic), while vitamin B12 injections and folate therapy treat megaloblastic anemia (macrocytic). Therefore, using erythropoietin plus stopping blood loss best fits the usual treatment for normocytic anemia.